Bouare N, Delwaide J. Fibroscan and fibrosis-4 in recovered hepatitis C patients. World J Gastroenterol 2026; 32(30): 117164 [DOI: 10.3748/wjg.117164]
Corresponding Author of This Article
Nouhoum Bouare, PhD, Senior Researcher, Department of Quality, Hygien, Biosafety/Biosecurity and Pharmacovigilence, National Institute of Public Health, Hippodrome Rue Hamilcar Cabral Bamako, Bamako 1771, Mali. nouhoumsamakoro@yahoo.fr
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Aug 14, 2026; 32(30): 117164 Published online Aug 14, 2026. doi: 10.3748/wjg.117164
Fibroscan and fibrosis-4 in recovered hepatitis C patients
Nouhoum Bouare, Jean Delwaide
Nouhoum Bouare, Department of Quality, Hygien, Biosafety/Biosecurity and Pharmacovigilence, National Institute of Public Health, Bamako 1771, Mali
Jean Delwaide, Department of Gastroenterology and Hepatology, CHULiege, Liege 4000, Belgium
Co-first authors: Nouhoum Bouare and Jean Delwaide.
Author contributions: Bouare N and Delwaide J contributed to the design, drafting, and review of the manuscript; all authors have read and approved the final version of this manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Corresponding author: Nouhoum Bouare, PhD, Senior Researcher, Department of Quality, Hygien, Biosafety/Biosecurity and Pharmacovigilence, National Institute of Public Health, Hippodrome Rue Hamilcar Cabral Bamako, Bamako 1771, Mali. nouhoumsamakoro@yahoo.fr
Received: December 1, 2025 Revised: February 3, 2026 Accepted: March 6, 2026 Published online: August 14, 2026 Processing time: 235 Days and 9.7 Hours
Core Tip
Core Tip: This editorial comments on the work of da Silva et al to expand knowledge in the related research field on three subtopics: The concept of hepatitis C recovered patients, the place of non-invasive tests (NITs), including fibroscan and fibrosis-4, in the management of these patients, and future research directions. While this editorial comments on the interesting work of da Silva et al, it relies on the concept of patients recovering after direct-acting antiviral treatment, the relevance of NITs, and the pathobiology of the hepatitis C virus in the management of this disease. The latter supports the concept of patients recovering after hepatitis C virus eradication because the disappearance of the hepatitis C virus does not rule out the progression of liver fibrosis or hepatocellular carcinoma.
